Keratin 7 expression as an early marker of reflux-related columnar mucosa without intestinal metaplasia in the esophagus

Medical Science Monitor

Volumn 15, Issue 5, 2009, Pages

  Cabibi, Daniela ^a,b   Fiorentino, Eugenio ^a   Pantuso, Gianni ^a   Mastrosimone, Achille ^a   Callari, Cosimo ^a   Cacciatore, Matilde ^a   Campione, Maria ^a   Aragona, Francesco ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Barrett esophagus; Caudal type homeobox 2 (CDX2); Columnar mucosa; Gastroesophageal reflux; Keratin 7 (KRT7)

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; MUCIN 2; PROTEIN P53; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ESOPHAGOGASTRIC JUNCTION; HELICOBACTER PYLORI; HUMANS; INTESTINES; KERATIN-7; METAPLASIA;

EID: 66649121965     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sampliner RE: Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol, 2002; 97: 1888-1895
2. Takubo K, Vieth M, Aryal G et al: Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: a pathognomonic feature of Barrett's esophagus? Hum Pathol, 2005; 36(3): 269-274
3. th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004; 1399-1433
4. Coad RA, Shepherd NA:" Barrett's oesophagus: definition, diagnosis and pathogenesis. Current Diagnostic Pathology, 2003; 9(4): 218-227
5. Ormsby AH, Goldblum JR, Rice TW et al: Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol, 1999; 30: 288-294 (Pubitemid 29125148)
6. Ormsby AH, Vaezi MF, Richter JE et al: Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology, 2000; 119: 683-690
7. Taniere P, Borghi-Scoazec G, Saurin JC et al: Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Pathol, 2002; 26(9): 1213-1221 (Pubitemid 34969191)
8. Glickman JN, Wang H, Das KM et al: Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol, 2001; 25(1): 87-94 (Pubitemid 32001837)
9. Gulmann C, Shaqaqi OA, Grace A et al: Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus. Appl Immunohistochem Mol Morphol, 2004; 12(2): 142-147
10. Mohammed IA, Streutker CJ, Riddel RH: Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol, 2002; 15: 611-616 (Pubitemid 34666464)
11. Phillips RW, Frierson HF Jr, Moskaluk CA: Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol, 2003; 27: 1442-1447 (Pubitemid 37315196)
12. Groisman GM, Amar M, Meir A: Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Mod Pathol Mod Pathol, 2004; 17(10): 1282-1288 (Pubitemid 39312955)
13. Bian YS, Osterheld MC, Bosman FT et al: p53 gGene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol, 2001; 14: 397-403 (Pubitemid 32448736)
14. Skacel M, Petras RE, Rybicki LA et al: p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression. Am J Gastroenterol, 2002; 97(10): 2508-2513
15. Weston AP, Banerjee SK, Sharma P et al: p53 pProtein overexpression in low- grade dysplasia (LGD) in Barrett's esophagus. iImmunohistochemical marker predictive of progression. Am J Gastroenterol, 2001; 96: 1355-1362 (Pubitemid 32455059)
16. th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2004; 1435-1474
17. Batts KP: Barrett esophagus - more steps forward. Hum Pathol, 2001; 32: 357-359 (Pubitemid 32378296)
18. Ramaekers F, van Niekerk C, Poels L, Schaafsma E et al: Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol, 1990; 136(3): 641-655 (Pubitemid 20105931)
19. Van Niekerk C, Jap P, Ramaekers F et al: Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol, 1991; 165(2): 145-152
20. De Meester SR, Wickramasinghe KS, Hagen JA et al: Cytokcheratine and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol, 2002; 97(10): 2514-2523
21. Chandrasoma PT, Der R, Ma Y et al: Histologic classification of patients based on mapping biopsies of the gastroesophageal junction. Am J Surg Pathol, 2003; 27(7): 929-936 (Pubitemid 36758896)
22. Mukaisho K, Miwa K, Kumagai H et al: Gastric carcinogenesis by duodenal reflux through gut regenerative cell lineage. Dig Dis Sci, 2003; 48(11): 2153-2158 (Pubitemid 38037302)
23. Oksanen A, Sankila A, von Boguslawski K et al: Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infection. J Clin Pathol, 2005; 58: 376-381
24. Cabibi D, Licata A, Barresi E et al: Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract. Pathol Res Pract. 2003; 199(2): 65-70 (Pubitemid 36519496)
25. Chaves P, Cardoso P, de Almeida JC et al: Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation. Hum Pathol, 1999; 30(11): 1291-1295 (Pubitemid 29534289)
26. Chandrasoma P: Controversies of the cardiac mucosa and Barrett's oesophagus. Histopathology, 2005; 46(4): 361-373 (Pubitemid 40516751)
27. Lombard C: Controversies of the cardiac mucosa and Barrett's oesophagus [comment]. Histopathology, 2006; 49(1): 97-98; author reply, 98 (Pubitemid 43972931)
28. Chandrasoma P: Controversies of the cardiac mucosa and Barrett's oesophagus [reply]. Histopathology, 2006; 49(1): 97-98 (Pubitemid 43972930)
29. Tastuta T, Mukaisho K, Sugihara H et al: Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux. Dig Dis Sci, 2005; 50(3): 425-431 (Pubitemid 40543726)
30. Chaves P, Cruz C, Dias Pereira A et al: Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma. Dis Esophagus, 2005; 18(6): 383-387 (Pubitemid 43904766)